This episode is probably a 400-level class in specialty pharmacy rebating. If you want a 45-minute conversation on rebates in all their glory, go back and listen to the conversation with Chris Sloan (Encore! EP216).
But if you’re still with me, what’s gonna follow is about an eight-minute overview of pharmaceutical rebating, just to make sure we’re all on the same page before we get into the show itself. So, if you know all there is to know about pharmaceutical rebating, you can jump ahead about eight minutes and get to the part where I talk with Pramod John.
Related Episodes
INBW36: Will Healthcare Stakeholders Who Don’t Collaborate Wind Up With a Business Problem?
We got two new reviews this week on the podcast, which I was thrilled to see. The first was from, it turns out, Dave Chase from Health Rosetta, who wrote that “with so many people in healthcare practicing ‘innovation theater’ and bloviating versus driving real change, it’s a breath of fresh air to ...
Encore! EP351: Everybody in the Healthcare Industry Getting Up in Everyone Else’s Business, With Eric Bricker, MD
This episode was one of the most popular episodes in the past 12 months. Since it aired, there was a show with Kevin Schulman, MD ( EP366 ), that added some context, which I would recommend, and also one with David Muhlestein, PhD, JD ( EP364 ). Those two shows and this one are a good three-pack. A...
EP385: Morgan Health and the 5 Things Self-insured Employers Should Do Right Now, With Dan Mendelson
If you listened to the show with Dan O’Neill ( EP359 ), you would know this already. But let me tell you: If you’re a provider, even a provider very confident in your office’s ability to confer better patient health, you will still have a super hard time getting off the fee-for-service (FFS) hamste...